Skip to content
For research use only. Not for human or veterinary use. Not a drug, food, or dietary supplement.
Cycle-length evidence

Semax cycle length: what human studies ran

Approved outside the USBLimited human data
Short answer: there is no established Semax cycle length, and we found no human studies that report one.

Treatment and follow-up in human studies

No human study durations are recorded.

What has not been tested

  • On-and-off schedules or breaks between courses.
  • Repeated courses and long-term exposure beyond the periods listed.
  • Semax combined with other compounds, unless a study above says so.

Frequently asked questions

Is there an established Semax cycle length?
No. We found no human studies that report a treatment duration for Semax.
What is the longest human study of Semax?
None is recorded.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.

References

  1. Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain J Neurochem. 2006
  2. Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents Neurochem Res. 2005
  3. The efficacy of semax in the treatment of patients at different stages of ischemic stroke (in Russian) Zh Nevrol Psikhiatr Im S S Korsakova. 2018
  4. Effectiveness of semax in acute period of hemispheric ischemic stroke: a clinical and electrophysiological study (in Russian) Zh Nevrol Psikhiatr Im S S Korsakova. 1997
  5. Semax in prevention of disease progress and development of exacerbations in patients with cerebrovascular insufficiency (in Russian) Zh Nevrol Psikhiatr Im S S Korsakova. 2005
  6. ACTH-like Peptides Compensate Rat Brain Gene Expression Profile Disrupted by Ischemia a Day After Experimental Stroke Biomedicines. 2024
  7. Development of Peptide Biopharmaceuticals in Russia Pharmaceutics. 2022
  8. Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion Int J Mol Sci. 2021
  9. DailyMed drug-label search for semax (conducted for this entry) FDA DailyMed. 2026
  10. WADA International Standard: Prohibited List 2026 (S0 and S2.2) WADA Prohibited List. 2026
  11. PubChem CID 9811102 (Semax) PubChem. 2026
  12. Genes That Associated with Action of ACTH-like Peptides with Neuroprotective Potential in Rat Brain Regions with Different Degrees of Ischemic Damage Int J Mol Sci. 2025
  13. ClinicalTrials.gov intervention search for semax (conducted for this entry) ClinicalTrials.gov. 2026